Muhammad Adrish, MD, MBA

Faculty @BCMDeptMedicine | Alum @IsenbergUMass @EinsteinMed @AllamaIqbalMed | Assoc Editor @BMJOpen_Resp | Interest: Airways #MedEd| #ProudPakiAmerican🇵🇰🇺🇸

[Muhammad Adrish, MD, MBA @AdrishMD]

@DanckersMD @JHUeducation @accpchest @atscommunity @APCCMPD Congratulations my friend!

[NEJM @NEJM]

Presented at #ACC26:

In patients with pulmonary embolism, ultrasound-facilitated, catheter-directed fibrinolysis led to a lower risk of a composite of major adverse outcomes than anticoagulation alone. Full HI-PEITHO trial results: https://t.co/itevLNqK0Z

Editorial: Advanced Therapy for Intermediate-Risk Pulmonary Embolism https://t.co/4YIifUjCwH

@ACCinTouch

[BCM PCCSM Section @BCM_Lung]

@BCMCME

[BCM PCCSM Section @BCM_Lung]

Mark Your Calendars: Advances in Pulmonary Medicine on Saturday, February 21, 2026

>Learn from world-renowned experts
>Attend in-person or virtually
>8.00 AMA Cat 1 Credits
>Registration Open: Free for any trainees/students
>Scan barcode

@BCM_ALD
@BCMDeptMedicine
@BCM_Alumni

[Muhammad Adrish, MD, MBA @AdrishMD]

Registration is open for this day long CME conference with top notch speakers. You can attend in person or watch it from the comfort of your couch. @bcmhouston @CHESTAirways

[BCM Clinician Resources @BCMCME]

🫁Register now: https://t.co/JgfMNtGzy4

[Nicola A. Hanania @Hananianick]

Advances in Pulmonary Medicine 2026- Baylor College of Medicine
https://t.co/mNIU5l9J0B
@BCMLungInst @BCM_Lung @BCMCME @bcmhouston

[Nicola A. Hanania @Hananianick]

@BCMLungInst @BCMCME @BCM_Lung

[Nicola A. Hanania @Hananianick]

Obstructive Lung Disease Academy at #CHEST2025 @AdrishMD @BCMCME @BCMLungInst @BCM_Lung

[ThoraxBMJ @ThoraxBMJ]

Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial. https://t.co/8gJnutqQxJ @mathioudakisag

[Muhammad Adrish, MD, MBA @AdrishMD]

Registration is OPEN!

Expand your knowledge & sharpen your skills at “Obstructive Lung Disease Academy: Hands-On Skills…Real Cases, Lasting Impact.” Saturday, October 18, 2025

Highlights of this session include:

>Case-based discussions on #asthma, #COPD and #Bronchiectasis
>Hands-on learning - Inhalers/airway clearance devices
>Interactive group discussions
>Games/Edutainment with @williamkellymd
>All-star faculty line-up Sandra Adams, @Hananianick @maselliMD @JerryKrishnan, Barry Make, Sanjay Devaranjan, @basavarajashwin, De De Gardner, Praveen Akuthota, Richard Branson, Jei Li and Jesse Sherratt

https://t.co/L8Y1v7gKT4

@accpchest @CHESTAirways @Shahidisheikh11 #CHEST2025

[Muhammad Adrish, MD, MBA @AdrishMD]

@SeragHashem Congratulations Dr El-Serag on a very impactful work.

[Muhammad Adrish, MD, MBA @AdrishMD]

Advances in Asthma Diagnosis and Management is now open for submissions until 5th January 2026. The link for the Call for Papers can be found here:  https://t.co/usHy5n2Feg

@BMJOpen_Resp

[CHEST® Journal @journal_CHEST]

INSIDE LOOK 👀 Read from the upcoming issue (July 8): Original research indicates that clinical remission is a realistic goal, sustainable up to two years in around one-third of patients w/ severe eosinophilic #asthma receiving benralizumab. https://t.co/RkElt5m1Ef
#JournalCHEST

[NEJM @NEJM]

Presented at #CCR25:

In a cluster-randomized, crossover trial, hospital-wide use of lactated Ringer’s solution as compared with normal saline did not alter the incidence of death or hospital readmission within 90 days. Full trial results: https://t.co/iF0oy3RrDf

@CritCareReviews

[ATS AII @ATS_AII]

Based on the results of the MATINEE, METREX, AND METREO studies, mepolizumab is now FDA approved for patients with COPD and eosinophilia! An exciting new development in the world of COPD.
#COPD #eosinophils

[Muhammad Adrish, MD, MBA @AdrishMD]

@williamkellymd Very well said sir!

[Muhammad Adrish, MD, MBA @AdrishMD]

Do you remember when you joined X? I do! #MyXAnniversary

[NEJM @NEJM]

Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) https://t.co/1K1FSMQERF

Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? https://t.co/SD8ix5qLqe

#ATS2025 | @atscommunity

[Muhammad Adrish, MD, MBA @AdrishMD]

Kudos to Kate and Phil for putting together an impressive review!!

[Nicola A. Hanania @Hananianick]

The Emerging Biomarkers in Chronic Obstructive Pulmonary Disease: A Narrative Review ⁦@BCM_Lung⁩ ⁦@BCMFromtheLabs⁩ ⁦@BCMCME⁩ ⁦@AdrishMD⁩ ⁦@CHESTAirways⁩ https://t.co/F9ihHY73B6